CIK: 1205442 - Address: 611 Gateway Boulevard, Suite 900, South San Francisco, CA 94080
21 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret21141-28-8-22-52-13
S%wins505743737010065

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/20/18 18:30
3/19/18
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOEVP,CFOS.m-24240.410-6-689D
2/20/18 20:22
2/15/18
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOEVP,CFOS.dm-61247.070-13-1295D
1/12/18 19:56
1/11/18
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOEVP,CFOS.dm-90124.350-37-2990D
1/2/18 19:14
12/29/17
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOEVP,CFOS-64020.000-32-2597D
8/17/17 17:36
8/15/17
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOEVP,CFOS.dm-6014.310-4-3121D
5/17/17 17:01
5/15/17
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOEVP,CFOS.dm-6015.115-4-3117D-600-271-26-4-34
3/23/17 20:06
3/22/17
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOEVP,CFOS.m-28920.656-14-11113D-45186293427-57-1-9-19
3/10/17 19:57
3/10/17
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOEVP,CFOS-48020.003-24-16127D-3814-12138202188-12-21
2/22/17 17:32
2/21/17
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOEVP,CFOS-13615.143-9-6151D-27-5-30-15-516-3-3-1442
11/14/16 16:45
11/10/16
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOCFOS.m-9919.844-5-589D-11-3524-12-2394314-7-14-14-25
10/13/16 17:22
10/11/16
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOCFOS.m-8717.473-5-594D-48-22-25-16-20-20-62-422-410
5/18/16 19:06
5/16/16
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOCFOS.d-8515.774-5-3183D-60-51-8-30-1465010273727
2/18/16 20:11
2/16/16
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOCFOS.d-9315.494-6-3173D-7-65-47-30-62253-5-20360
12/1/15 18:52
11/30/15
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOCFOS-24040.0010-6-1436D46-5-33110227-1-10-32-46-50-44
8/19/15 20:43
8/18/15
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOCFOS.d-29649.3814-6-1632D147301-16-44-9-144-32-63-50
6/16/15 20:09
6/15/15
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOCFOS-50050.0010-10-2727D10470364630267418-13-34-58
6/1/15 17:37
5/29/15
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcGrath JohnCAOCFOS-40040.008-10-2137D64117-1913121021126-2-5-55
11/13/07 19:18
11/12/07
NWKNetwork Equipment Technologies IncDETechCNtwkComputer Communications EquipMcGrath JohnCAOEXC.112.S.d-30812.313-25-6414D145951921-24-22-14-1064-11-51-59-82
8/20/07 17:46
8/16/07
NWKNetwork Equipment Technologies IncDETechCNtwkComputer Communications EquipMcGrath JohnCAOEXC.112.S.dm-20910.083-21-5617D1082029502175-113725-43-65
8/16/07 15:04
8/15/07
NWKNetwork Equipment Technologies IncDETechCNtwkComputer Communications EquipMcGrath JohnCAOEXC.112.S.d-4310.012-4-2117D982052209-32503424-39-62
8/2/05 20:22
7/29/05
ENWVEndwave CorpDEElectrTvEqRadio & Tv Broadcasting & ComMcGrath JohnCADS.d-7935.770-2-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact